Regular Article
Modeling Plasma Virus Concentration during Primary HIV Infection

https://doi.org/10.1006/jtbi.2000.1076Get rights and content

Abstract

During primary HIV infection the viral load in plasma increases, reaches a peak, and then declines. Phillips has suggested that the decline is due to a limitation in the number of cells susceptible to HIV infection, while other authors have suggested that the decline in viremia is due to an immune response. Here we address this issue by developing models of primary HIV-1 infection, and by comparing predictions from these models with data from ten anti-retroviral, drug-naive, infected patients. Applying nonlinear least-squares estimation, we find that relatively small variations in parameters are capable of mimicking the highly diverse patterns found in patient viral load data. This approach yields an estimate of 2.5 days for the average lifespan of productively infected cells during primary infection, a value that is consistent with results obtained by drug perturbation experiments. We find that the data from all ten patients are consistent with a target-cell-limited model from the time of initial infection until shortly after the peak in viremia. However, the kinetics of the subsequent fall and recovery in virus concentration in some patients are not consistent with the predictions of the target-cell-limited model. We illustrate that two possible immune response mechanisms, cytotoxic T lymphocyte destruction of infected target cells and cytokine suppression of viral replication, could account for declines in viral load data not predicted by the original target-cell-limited model. We conclude that some additional process, perhaps mediated by CD8+ T cells, is important in at least some patients.

References (58)

  • P. BORROW et al.

    Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

    Nat. Med.

    (1997)
  • S.J. CLARK et al.

    High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

    New Engl. J. Med.

    (1991)
  • K.L. COLLINS et al.

    HIV-1 nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

    Nature

    (1998)
  • E.S. DAAR et al.

    Transient high levels of viremia in patients with primary human immunodeficiency virus type 1

    New Engl. J. Med.

    (1991)
  • D.Z. D'ARGENIO et al.

    ADAPT II User's Guide: Pharmacokinetic/Pharmacodynamics Systems Analysis Software

    (1997)
  • L.G. GUIDOTTI et al.

    Viral clearance without destruction of infected cells during acute HBV infection

    Science

    (1999)
  • A.T. HAASE

    Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues

    Ann. Rev. Immunol.

    (1999)
  • D.D. HO et al.

    Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

    Nature

    (1995)
  • X. JIN et al.

    Dramatic rise in plasma viremia after CD8+ T-cell depletion in SIV-infected macaques

    J. Exp. Med.

    (1999)
  • J.O. KAHN et al.

    Acute human immunodeficiency virus type 1 infection

    New Engl. J. Med.

    (1998)
  • G.R. KAUFMANN et al.

    Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection

    J. Infec. Dis.

    (1998)
  • D.E. KIRSCHNER et al.

    Role of the thymus in pediatric HIV-1 infection

    J. AIDS Human Retrovirol.

    (1998)
  • P. KLENERMAN et al.

    Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection

    Proc. Nat. Acad. Sci. U.S.A.

    (1996)
  • R.A. KOUP et al.

    Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

    J. Virol.

    (1994)
  • S.J. LITTLE et al.

    Viral dynamics of acute HIV-1 infection

    J. Exp. Med.

    (1999)
  • J.W. MACIASZEK et al.

    IL-16 represses HIV-1 promoter activity

    J. Immunol.

    (1997)
  • C.E. MACKEWICZ et al.

    CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription

    Proc. Nat. Acad. Sci. U.S.A.

    (1995)
  • T. MATANO et al.

    Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques

    J. Virol.

    (1998)
  • Cited by (386)

    • Sliding mode control theory interprets elite control of HIV

      2022, Feedback Control for Personalized Medicine
    View all citing articles on Scopus

    Author to whom correspondence should be addressed.

    View full text